...
首页> 外文期刊>Medicine. >Fibrosing Mediastinitis: Clinical Presentation, Therapeutic Outcomes, and Adaptive Immune Response
【24h】

Fibrosing Mediastinitis: Clinical Presentation, Therapeutic Outcomes, and Adaptive Immune Response

机译:纤维化纵隔炎:临床表现,治疗结果和适应性免疫反应

获取原文
           

摘要

Fibrosing mediastinitis (FM) is a rare disorder characterized by the invasive proliferation of fibrous tissue within the mediastinum. FM frequently results in the compression of vital mediastinal structures and has been associated with substantial morbidity and mortality. Its pathogenesis remains unknown. However, in North America most cases are thought to represent an immune-mediated hypersensitivity response to Histoplasma capsulatum infection. To characterize the clinical disease spectrum, natural disease progression, responses to therapy, and overall survival, we retrospectively analyzed all 80 consecutive patients with a diagnosis of FM evaluated at Mayo Clinic, Rochester, MN, from 1998 to 2007. Furthermore, we characterized the adaptive immune response in 15 representative patients by immunohistochemistry. The majority of patients presented with nonspecific respiratory symptoms due to the compression of mediastinal broncho-vascular structures. Chest radiographic imaging most frequently revealed localized, invasive, and frequently calcified right-sided mediastinal masses. Most patients had radiographic or serologic evidence of previous histoplasmosis. In contrast to earlier reports summarizing previously reported FM cases, the clinical course of our patients appeared to be more benign and less progressive. The overall survival was similar to that of age-matched controls. There were only 5 deaths, 2 of which were attributed to FM. These differences may reflect publication bias associated with the preferential reporting of more severely affected FM patients in the medical literature, as well as the more inclusive case definition used in our consecutive case series. Surgical and nonsurgical interventions effectively relieved symptoms caused by the compression of mediastinal vascular structures in these carefully selected patients. In contrast, antifungal and antiinflammatory agents appeared ineffective. Histologic examination and immunostaining revealed mixed inflammatory infiltrates consistent with a fibroinflammatory tissue response in these histoplasmosis-associated FM cases. The immune cell infiltrates included large numbers of CD20-positive B lymphocytes. As B lymphocytes may contribute to the pathogenesis of the disease, therapeutic B-cell depletion should be investigated as a therapeutic strategy for FM. Abbreviations: CT = computed tomography, FM = fibrosing mediastinitis, PET = positron emission tomography, SVC = superior vena cava.
机译:纤维化纵隔炎(FM)是一种罕见的疾病,其特征在于纵隔内纤维组织的侵入性增生。 FM经常导致重要的纵隔结构受压,并伴有大量发病率和死亡率。其发病机理仍然未知。然而,在北美,大多数情况被认为代表了对荚膜胞浆菌感染的免疫介导的超敏反应。为了表征临床疾病谱,自然疾病的进展,对治疗的反应以及总生存期,我们回顾性分析了1998年至2007年在明尼苏达州罗切斯特市梅奥诊所评估的所有FM诊断连续的80例患者。通过免疫组织化学对15名代表性患者进行适应性免疫反应。由于纵隔支气管血管结构受压,大多数患者出现非特异性呼吸道症状。胸部X线影像学检查最常显示右侧纵隔肿块,局部浸润和钙化。大多数患者具有先前组织胞浆菌病的影像学或血清学证据。与总结先前报道的FM病例的早期报道相比,我们患者的临床病程似乎更为良性且进展较少。总体存活率与年龄匹配的对照组相似。只有5例死亡,其中2例归因于FM。这些差异可能反映了与医学文献中较严重的FM患者优先报告有关的发表偏倚,以及我们连续病例系列中使用的更具包容性的病例定义。手术和非手术干预可有效缓解这些精心挑选的患者中纵隔血管结构受压所引起的症状。相反,抗真菌药和抗炎药似乎无效。组织学检查和免疫染色显示,在这些与组织胞浆菌病相关的FM病例中,混合的炎性浸润与纤维炎性组织反应一致。免疫细胞浸润包括大量CD20阳性B淋巴细胞。由于B淋巴细胞可能与疾病的发病机理有关,因此应研究治疗性B细胞耗竭作为FM的治疗策略。缩写:CT =计算机断层扫描,FM =纤维化纵隔炎,PET =正电子发射断层扫描,SVC =上腔静脉。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号